Show simple item record

dc.contributor.authorBerry, JM
dc.contributor.authorHoward, PW
dc.contributor.authorKelland, LR
dc.contributor.authorThurston, DE
dc.date.accessioned2018-09-18T10:35:40Z
dc.date.issued2002-05-20
dc.identifier10
dc.identifier.citationBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 pp. 1413 - 1416
dc.identifier.issn0960-894X
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2761
dc.identifier.doi10.1016/S0960-894X(02)00150-6
dc.description.abstractThe first example of an N10-protected. (e.g., Psec, 15) pyrrolo[2,1-c][1,4]benzodiazepine (PBD) analogue that retains significant cytotoxicity in a number of tumour cell lines is reported. This prototype could lead to a new generation of clinically useful N10-protceted PBD prodrugs. (C) 2002 Published by Elsevier Science Ltd.
dc.format.extent1413 - 1416
dc.languageeng
dc.language.isoeng
dc.titleSynthesis and biological evaluation of an N10-Psec substituted pyrrolo[2,1-c][1,4]benzodiazepine prodrug
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/S0960-894X(02)00150-6
rioxxterms.licenseref.startdate2002-05-20
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBIOORGANIC & MEDICINAL CHEMISTRY LETTERS
pubs.notesarticle-number: PII S0960-894X(02)00150-6 unique-id: ISI:000175648800020
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR
pubs.volume12
pubs.embargo.termsNot known
dc.contributor.icrauthorKelland, Lloyden


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following collection(s)

Show simple item record